|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Amortization of intangibles | |||||
| Restructuring and asset related charges - net | |||||
| Acquisition, integration and separation costs | |||||
| Equity in (loss) earnings of nonconsolidated affiliates | |||||
| Sundry income (expense) - net | |||||
| Interest expense | |||||
| Income (loss) from continuing operations before income taxes | |||||
| Provision for (benefit from) income taxes on continuing operations | |||||
| Income (loss) from continuing operations, net of tax | |||||
| (Loss) income from discontinued operations, net of tax | |||||
| Net (loss) income | |||||
| Net income attributable to noncontrolling interests | |||||
| Net (loss) income available for DuPont common stockholders | |||||
| Per common share data: | |||||
| Earnings (loss) per common share from continuing operations - basic (in USD per share) | |||||
| (Loss) earnings per common share from discontinued operations - basic (in USD per share) | |||||
| (Loss) earnings per common share - basic (in USD per share) | |||||
| Earnings (loss) per common share from continuing operations - diluted (in USD per share) | |||||
| (Loss) earnings per common share from discontinued operations - diluted (in USD per share) | |||||
| (Loss) earnings per common share - diluted (in USD per share) | |||||
| Weighted-average common shares outstanding - basic (in shares) | |||||
| Weighted-average common shares outstanding - diluted (in shares) |
Loading...
